In one paragraphArticle in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Paeton L WantuchDepartment of Pediatrics, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0002-6993-6320 Jessica TungDepartment of Pediatrics, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0001-6388-4868 Lloyd S RobinsonOmniose, St. Louis, MO 63110, USA.
Cory J KnootOmniose, St. Louis, MO 63110, USA.
Drew J SchwartzDepartment of Pediatrics, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0003-1568-7733 David A RosenDepartment of Pediatrics, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0003-1081-772X Funding
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent KlebsiellaR01AI175038 · NIAID · WASHINGTON UNIVERSITY · PI ROSEN, DAVID A. · 2023 to 2025
$3.5MA capsule-based bioconjugate vaccine to prevent Klebsiella pneumoniae infectionsR44AI167078 · NIAID · VAXNEWMO, LLC · PI Christian Harding · 2025 to 2026
$2.0MAntibiotic disruption of the gut microbiome and immune response in neonatal late-onset sepsisK08AI159384 · NIAID · WASHINGTON UNIVERSITY · PI SCHWARTZ, DREW JOEL · 2021 to 2025
$785kMaternal vaccination to prevent Klebsiella pneumoniae gut colonization and neonatal sepsisR01AI195492 · NIAID · WASHINGTON UNIVERSITY · PI David A. Rosen, DREW Joel SCHWARTZ · 2026 to 2026
$727kNIAID NIH HHS K08 AI159384NIAID NIH HHS R01 AI175038NIAID NIH HHS R01 AI195492NIAID NIH HHS R44 AI167078
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Bacterial CapsulesBacterial VaccinesKlebsiella InfectionsKlebsiella pneumoniaeNeonatal SepsisPolysaccharides, BacterialAnimalsAnimals, NewbornAntibodies, BacterialDisease Models, AnimalFemaleImmunity, Maternally-AcquiredMicePregnancyVaccinationVaccines, ConjugateAntibodies, BacterialBacterial VaccinesPolysaccharides, BacterialVaccines, Conjugate
Identifiers
PMID42873859
PMCPMC13665941
What OpenQuestion holds
Textmetadata
Read underepoch 390